Historical shareholding details of DFA US Targeted Value Portfolio holdings in Anika Therapeutics Inc. (ANIK)

Monthly changes of DFA US Targeted Value Portfolio shareholding in Anika Therapeutics Inc. over the previous months

Month Name Total no. shares held Percent Holding
Jan 31, 2025 Dfa Us Targeted Value Portfolio 112,337 0.78%
Dec 31, 2024 Dfa Us Targeted Value Portfolio 112,337 0.77%
Nov 30, 2024 Dfa Us Targeted Value Portfolio 112,337 0.77%
Oct 31, 2024 Dfa Us Targeted Value Portfolio 114,699 0.78%
Sep 30, 2024 Dfa Us Targeted Value Portfolio 118,241 0.81%
Aug 31, 2024 Dfa Us Targeted Value Portfolio 122,003 0.82%
Jul 31, 2024 Dfa Us Targeted Value Portfolio 126,602 0.86%
Jun 30, 2024 Dfa Us Targeted Value Portfolio 130,525 0.88%
May 31, 2024 Dfa Us Targeted Value Portfolio 132,018 0.91%
Apr 30, 2024 Dfa Us Targeted Value Portfolio 137,286 0.94%
Mar 31, 2024 Dfa Us Targeted Value Portfolio 137,286 0.93%
Feb 29, 2024 Dfa Us Targeted Value Portfolio 137,286 0.93%
Jan 31, 2024 Dfa Us Targeted Value Portfolio 137,286 0.92%
Dec 31, 2023 Dfa Us Targeted Value Portfolio 144,099 0.98%
Oct 31, 2023 Dfa Us Targeted Value Portfolio 147,001 1.00%
Sep 30, 2023 Dfa Us Targeted Value Portfolio 209,548 1.43%
Jul 31, 2023 Dfa Us Targeted Value Portfolio 135,748 0.93%
Jun 30, 2023 Dfa Us Targeted Value Portfolio 110,111 0.75%
Apr 30, 2023 Dfa Us Targeted Value Portfolio 108,043 0.73%

View all ownership details of Anika Therapeutics Inc.